Supercharging Immunotherapy August 2022 Disclaimer This presentation and other related material may contain a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding HOOKIPA's expectation about any or all of the following: (i) the success, cost and timing of HOOKIPA's product development activities and clinical trials; (ii) the timing, scope or likelihood of regulatory filings and approvals, including timin ...

Supercharging Immunotherapy June 2022 Disclaimer This presentation and other related material may contain a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding HOOKIPA's expectation about any or all of the following: (i) the success, cost and timing of HOOKIPA's product development activities and clinical trials; (ii) the timing, scope or likelihood of regulatory filings and approvals, including timing ...

Supercharging Immunotherapy May 2022 Disclaimer This presentation and other related material may contain a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding HOOKIPA's expectation about any or all of the following: (i) the success, cost and timing of HOOKIPA's product development activities and clinical trials; (ii) the timing, scope or likelihood of regulatory filings and approvals, including timing o ...

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2021 Earnings Conference Call March 24, 2022 8:30 AM ET Company Participants Matthew Beck - Executive Director, Investor Relations Joern Aldag - Chief Executive Officer Reinhard Kandera - Chief Financial Officer Igor Matushansky - Chief Medical Officer & Global Head of Research Development Conference Call Participants Andrew Berens - SVB Leerink RK - H.C. Wainwright Roy Buchanan - JMP Securities Operator Good day, and thank you for standing by. Welcome to the HOOKIPA Fou ...

| --- | --- | --- | --- | |-------|-------|---------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | Q4 and FY 2021 Financials | | | | | | | | | | | | | | | & Corporate Update | | | | | | | | | | | | | | | | | | | | | | | | | | | Leadership Present At This Earnings Call | --- | --- | --- | |-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------ ...

Supercharging Immunotherapy June 2021 Disclaimer This presentation and other related material may contain a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding HOOKIPA's expectation about any or all of the following: (i) the success, cost and timing of HOOKIPA's product development activities and clinical trials; (ii) the timing, scope or likelihood of regulatory filings and approvals, including timing ...

Supercharging Immunotherapy May 2021 Disclaimer This presentation and other related material may contain a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding HOOKIPA's expectation about any or all of the following: (i) the success, cost and timing of HOOKIPA's product development activities and clinical trials; (ii) the timing, scope or likelihood of regulatory filings and approvals, including timing o ...

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2020 Results Conference Call March 18, 2021 8:30 AM ET Company Participants Matthew Beck - Head of Investor Relations Joern Aldag - Chief Executive Officer Reinhard Kandera - Chief Financial Officer Igor Matushansky - Chief Medical Officer and Head of Global Research and Development Christine Baker - Chief Business Officer Roman Necina - Chief Technology Officer Conference Call Participants Alec Stranahan - Bank of America Securities Ingrid Gafanhão - Kempen Roy Buchanan ...

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2019 Earnings Conference Call March 19, 2020 8:00 AM ET Company Participants Matthew Beck - Executive Director, Investor Relations Joern Aldag - CEO Reinhard Kandera - CFO Igor Matushansky - CMO Roman Necina - CTO Conference Call Participants Andrew Berens - SVB Leerink Alec Stranahan - Bank of America Brian Abrahams - RBC Capital Markets Suzanne van Voorthuizen - Kempen Operator Good morning, and thank you for joining the HOOKIPA Pharma Fourth Quarter and Full Year 2019 ...

Supercharging Immunotherapy November 2019 This presentation and other related material may contain a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding HOOKIPA's expectation about any or all of the following: (i) the success, cost and timing of HOOKIPA's product development activities and clinical trials; (ii) the timing, scope or likelihood of regulatory filings and approvals, including timing of Inve ...